
Sign up to save your podcasts
Or


Based on Podcast App listening data
Our lives currently revolve around the global emergency of COVID-19; you’re probably reading this while confined to your house, as the death toll from the worst pandemic since 1918 continues to rise.
The question of how to tackle COVID-19 has been foremost in the minds of many, including here at 80,000 Hours.
Today's guest, Dr Gregory Lewis, acting head of the Biosecurity Research Group at Oxford University's Future of Humanity Institute, puts the crisis in context, explaining how COVID-19 compares to other diseases, pandemics of the past, and possible worse crises in the future.
COVID-19 is a vivid reminder that we are unprepared to contain or respond to new pathogens.
How would we cope with a virus that was even more contagious and even more deadly? Greg's work focuses on these risks -- of outbreaks that threaten our entire future through an unrecoverable collapse of civilisation, or even the extinction of humanity.
Links to learn more, summary and full transcript.
If such a catastrophe were to occur, Greg believes it’s more likely to be caused by accidental or deliberate misuse of biotechnology than by a pathogen developed by nature.
There are a few direct causes for concern: humans now have the ability to produce some of the most dangerous diseases in history in the lab; technological progress may enable the creation of pathogens which are nastier than anything we see in nature; and most biotechnology has yet to even be conceived, so we can’t assume all the dangers will be familiar.
This is grim stuff, but it needn’t be paralysing. In the years following COVID-19, humanity may be inspired to better prepare for the existential risks of the next century: improving our science, updating our policy options, and enhancing our social cohesion.
COVID-19 is a tragedy of stunning proportions, and its immediate threat is undoubtedly worthy of significant resources.
But we will get through it; if a future biological catastrophe poses an existential risk, we may not get a second chance. It is therefore vital to learn every lesson we can from this pandemic, and provide our descendants with the security we wish for ourselves.
Today’s episode is the hosting debut of our Strategy Advisor, Howie Lempel.
80,000 Hours has focused on COVID-19 for the last few weeks and published over ten pieces about it, and a substantial benefit of this interview was to help inform our own views. As such, at times this episode may feel like eavesdropping on a private conversation, and it is likely to be of most interest to people primarily focused on making the long-term future go as well as possible.
In this episode, Howie and Greg cover:
• Reflections on the first few months of the pandemic
• Common confusions around COVID-19
• How COVID-19 compares to other diseases
• What types of interventions have been available to policymakers
• Arguments for and against working on global catastrophic biological risks (GCBRs)
• How to know if you’re a good fit to work on GCBRs
• The response of the effective altruism community, as well as 80,000 Hours in particular, to COVID-19
• And much more.
Chapters:
Get this episode by subscribing: type '80,000 Hours' into your podcasting app. Or read the linked transcript.
Producer: Keiran Harris.
Audio mastering: Ben Cordell.
Transcriptions: Zakee Ulhaq.
In a few days we'll be putting out a conversation with Dr Greg Lewis, who studies how to prevent global catastrophic biological risks at Oxford's Future of Humanity Institute.
From home isolation Rob and Howie just recorded an episode on:
1. How many could die in the crisis, and the risk to your health personally.
2. What individuals might be able to do help tackle the coronavirus crisis.
3. What we suspect governments should do in response to the coronavirus crisis.
4. The importance of personally not spreading the virus, the properties of the SARS-CoV-2 virus, and how you can personally avoid it.
5. The many places society screwed up, how we can avoid this happening again, and why be optimistic.
To do good, most of us look to use our time and money to affect the world around us today. But perhaps that's all wrong.
If you took $1,000 you were going to donate and instead put it in the stock market — where it grew on average 5% a year — in 100 years you'd have $125,000 to give away instead. And in 200 years you'd have $17 million.
This astonishing fact has driven today's guest, economics researcher Philip Trammell at Oxford's Global Priorities Institute, to investigate the case for and against so-called 'patient philanthropy' in depth. If the case for patient philanthropy is as strong as Phil believes, many of us should be trying to improve the world in a very different way than we are now.
He points out that on top of being able to dispense vastly more, whenever your trustees decide to use your gift to improve the world, they'll also be able to rely on the much broader knowledge available to future generations. A donor two hundred years ago couldn't have known distributing anti-malarial bed nets was a good idea. Not only did bed nets not exist — we didn't even know about germs, and almost nothing in medicine was justified by science.
ADDED: Does the COVID-19 emergency mean we should actually use resources right now? See Phil's first thoughts on this question here.
• Links to learn more, summary and full transcript.
What similar leaps will our descendants have made in 200 years, allowing your now vast foundation to benefit more people in even greater ways?
And there's a third reason to wait as well. What are the odds that we today live at the most critical point in history, when resources happen to have the greatest ability to do good? It's possible. But the future may be very long, so there has to be a good chance that some moment in the future will be both more pivotal and more malleable than our own.
Of course, there are many objections to this proposal. If you start a foundation you hope will wait around for centuries, might it not be destroyed in a war, revolution, or financial collapse?
Or might it not drift from its original goals, eventually just serving the interest of its distant future trustees, rather than the noble pursuits you originally intended?
Or perhaps it could fail for the reverse reason, by staying true to your original vision — if that vision turns out to be as deeply morally mistaken as the Rhodes' Scholarships initial charter, which limited it to 'white Christian men'.
Alternatively, maybe the world will change in the meantime, making your gift useless. At one end, humanity might destroy itself before your trust tries to do anything with the money. Or perhaps everyone in the future will be so fabulously wealthy, or the problems of the world already so overcome, that your philanthropy will no longer be able to do much good.
Are these concerns, all of them legitimate, enough to overcome the case in favour of patient philanthropy? In today's conversation with researcher Phil Trammell and my 80,000 Hours colleague Howie Lempel, we try to answer that, and also discuss:
• Real attempts at patient philanthropy in history and how they worked out
• Should we have a mixed strategy, where some altruists are patient and others impatient?
• Which causes most need money now, and which later?
• What is the research frontier here?
• What does this all mean for what listeners should do differently?
Chapters:
Producer: Keiran Harris.
Audio mastering: Ben Cordell.
Transcriptions: Zakee Ulhaq.
nCoV is alarming governments and citizens around the world. It has killed more than 1,000 people, brought the Chinese economy to a standstill, and continues to show up in more and more places. But bad though it is, it's much closer to a warning shot than a worst case scenario. The next emerging infectious disease could easily be more contagious, more fatal, or both.
Despite improvements in the last few decades, humanity is still not nearly prepared enough to contain new diseases. We identify them too slowly. We can't do enough to reduce their spread. And we lack vaccines or drugs treatments for at least a year, if they ever arrive at all.
• Links to learn more, summary and full transcript.
This is a precarious situation, especially with advances in biotechnology increasing our ability to modify viruses and bacteria as we like.
In today's episode, Cassidy Nelson, a medical doctor and research scholar at Oxford University's Future of Humanity Institute, explains 12 things her research group think urgently need to happen if we're to keep the risk at acceptable levels. The ideas are:
Science
1. Roll out genetic sequencing tests that lets you test someone for all known and unknown pathogens in one go.
2. Fund research into faster ‘platform’ methods for going from pathogen to vaccine, perhaps using innovation prizes.
3. Fund R&D into broad-spectrum drugs, especially antivirals, similar to how we have generic antibiotics against multiple types of bacteria.
Response
4. Develop a national plan for responding to a severe pandemic, regardless of the cause. Have a backup plan for when things are so bad the normal processes have stopped working entirely.
5. Rigorously evaluate in what situations travel bans are warranted. (They're more often counterproductive.)
6. Coax countries into more rapidly sharing their medical data, so that during an outbreak the disease can be understood and countermeasures deployed as quickly as possible.
7. Set up genetic surveillance in hospitals, public transport and elsewhere, to detect new pathogens before an outbreak — or even before patients develop symptoms.
8. Run regular tabletop exercises within governments to simulate how a pandemic response would play out.
Oversight
9. Mandate disclosure of accidents in the biosafety labs which handle the most dangerous pathogens.
10. Figure out how to govern DNA synthesis businesses, to make it harder to mail order the DNA of a dangerous pathogen.
11. Require full cost-benefit analysis of 'dual-use' research projects that can generate global risks.
12. And finally, to maintain momentum, it's necessary to clearly assign responsibility for the above to particular individuals and organisations.
These advances can be pursued by politicians and public servants, as well as academics, entrepreneurs and doctors, opening the door for many listeners to pitch in to help solve this incredibly pressing problem.
In the episode Rob and Cassidy also talk about:
• How Cassidy went from clinical medicine to a PhD studying novel pathogens with pandemic potential.
• The pros, and significant cons, of travel restrictions.
• Whether the same policies work for natural and anthropogenic pandemics.
• Ways listeners can pursue a career in biosecurity.
• Where we stand with nCoV as of today.
Chapters:
Get this episode by subscribing: type 80,000 Hours into your podcasting app. Or read the linked transcript.
Producer: Keiran Harris.
Transcriptions: Zakee Ulhaq.
The State Council of China's 2017 AI plan was the starting point of China’s AI planning; China’s approach to AI is defined by its top-down and monolithic nature; China is winning the AI arms race; and there is little to no discussion of issues of AI ethics and safety in China. How many of these ideas have you heard?
In his paper Deciphering China's AI Dream, today's guest, PhD student Jeff Ding, outlines why he believes none of these claims are true.
• Links to learn more, summary and full transcript.
• What’s the best charity to donate to?
He first places China’s new AI strategy in the context of its past science and technology plans, as well as other countries’ AI plans. What is China actually doing in the space of AI development?
Jeff emphasises that China's AI strategy did not appear out of nowhere with the 2017 state council AI development plan, which attracted a lot of overseas attention. Rather that was just another step forward in a long trajectory of increasing focus on science and technology. It's connected with a plan to develop an 'Internet of Things', and linked to a history of strategic planning for technology in areas like aerospace and biotechnology.
And it was not just the central government that was moving in this space; companies were already pushing forward in AI development, and local level governments already had their own AI plans. You could argue that the central government was following their lead in AI more than the reverse.
What are the different levers that China is pulling to try to spur AI development?
Here, Jeff wanted to challenge the myth that China's AI development plan is based on a monolithic central plan requiring people to develop AI. In fact, bureaucratic agencies, companies, academic labs, and local governments each set up their own strategies, which sometimes conflict with the central government.
Are China's AI capabilities especially impressive? In the paper Jeff develops a new index to measure and compare the US and China's progress in AI.
Jeff’s AI Potential Index — which incorporates trends and capabilities in data, hardware, research and talent, and the commercial AI ecosystem — indicates China’s AI capabilities are about half those of America. His measure, though imperfect, dispels the notion that China's AI capabilities have surpassed the US or make it the world's leading AI power.
Following that 2017 plan, a lot of Western observers thought that to have a good national AI strategy we'd need to figure out how to play catch-up with China. Yet Chinese strategic thinkers and writers at the time actually thought that they were behind — because the Obama administration had issued a series of three white papers in 2016.
Finally, Jeff turns to the potential consequences of China’s AI dream for issues of national security, economic development, AI safety and social governance.
He claims that, despite the widespread belief to the contrary, substantive discussions about AI safety and ethics are indeed emerging in China. For instance, a new book from Tencent’s Research Institute is proactive in calling for stronger awareness of AI safety issues.
In today’s episode, Rob and Jeff go through this widely-discussed report, and also cover:
• The best analogies for thinking about the growing influence of AI
• How do prominent Chinese figures think about AI?
• Coordination with China
• China’s social credit system
• Suggestions for people who want to become professional China specialists
• And more.
Chapters:
Producer: Keiran Harris.
Audio mastering: Ben Cordell.
Transcriptions: Zakee Ulhaq.
Two 80,000 Hours researchers, Robert Wiblin and Howie Lempel, record an experimental bonus episode about the new 2019-nCoV virus.
See this list of resources, including many discussed in the episode, to learn more.
In the 1h15m conversation we cover:
• What is it?
• How many people have it?
• How contagious is it?
• What fraction of people who contract it die?
• How likely is it to spread out of control?
• What's the range of plausible fatalities worldwide?
• How does it compare to other epidemics?
• What don't we know and why?
• What actions should listeners take, if any?
• How should the complexities of the above be communicated by public health professionals?
Here's a link to the hygiene advice from Laurie Garrett mentioned in the episode.
Recorded 2 Feb 2020.
The 80,000 Hours Podcast is produced by Keiran Harris.
From the publisher's feed
Ranked by our users in the last 21 days

26,249 Listeners

2,451 Listeners

1,087 Listeners

606 Listeners

123 Listeners

288 Listeners

1,621 Listeners

204 Listeners

98 Listeners

565 Listeners

510 Listeners

5,557 Listeners

140 Listeners

145 Listeners

89 Listeners